FDA issues warning to MKS Enterprise for selling honey containing undeclared tadalafil and making unapproved drug claims. • Product: Dose Vital Royal Honey with tadalafil confirmed via lab analysis • Violates FD&C Act: added drug in food, unapproved new drug, misbranding • Claims on website: treatment for arthritis, cholesterol, liver, prostate, and more • Regulatory action: warning letter, 15-day response deadline, potential seizure or injunction • Tadalafil presence: FDA confirms illegal addition, unsafe interactions with nitrates Original Press Release: www.fda.gov/inspection... #FDA #USFDA
FDA warns Boner Bears Chocolate contains undeclared sildenafil, posing risks for those on nitrates; avoid use. • Contains hidden prescription drug ingredient, Viagra’s sildenafil • Risks include dangerous blood pressure drops, especially with nitrates • Promoted as natural, but may contain harmful chemicals • Affects consumers seeking sexual enhancement, weight loss, or bodybuilding products • Report adverse effects via FDA’s MedWatch program Original Press Release: www.fda.gov/drugs/medi... #FDA #USFDA
FDA warns DTF Sexual Chocolate contains undeclared sildenafil, tadalafil; risks dangerous interactions. • Contains prescription ED drugs, not listed on label • May cause severe blood pressure drops, especially with nitrates • Sold online, marketed as natural supplement for sexual enhancement • Consumers, healthcare providers urged to report adverse effects • Warning highlights risks of hidden drug ingredients in supplements Original Press Release: www.fda.gov/drugs/medi... #FDA #USFDA
FDA warns Fantasy Aphrodisiac Chocolate contains undeclared sildenafil, posing risks for those on nitrates; avoid use. • Contains hidden sildenafil, a Viagra ingredient • Risks include dangerous blood pressure drops, especially with nitrates • Promoted as natural, but may contain unlisted pharmaceuticals • Sold online and in retail stores for sexual enhancement • Consumers and healthcare providers urged to report adverse effects Original Press Release: www.fda.gov/drugs/medi... #FDA #USFDA
FDA warns LOVION Chocolate with Ginseng for Men contains hidden sildenafil, tadalafil—risking dangerous interactions; avoid use. • Contains undeclared Viagra, Cialis ingredients • Promoted for sexual enhancement, sold online and in stores • Risks include severe blood pressure drops, especially with nitrates • Consumers, healthcare providers urged to report adverse effects • Caution advised on all "all natural" supplements with similar claims Original Press Release: www.fda.gov/drugs/medi... #FDA #USFDA
Two new drugs approved in 2026 expand treatment options for rare and common conditions • Zycubo (copper histidinate) approved 1/12/2026 for Menkes disease • Adquey (difamilast) approved 2/12/2026 for mild to moderate atopic dermatitis • Both mark first approvals for these novel active ingredients • Indications and dosing details available in latest FDA prescribing info • Significance for rare disease and dermatology markets Original Press Release: www.fda.gov/drugs/nove... #FDA #USFDA
Electrical safety risks prompt recall of Medline homecare beds after reports of fires, injuries, and fatalities; follow updated use instructions. • Medline issued safety correction for specific semi and full electric beds • Incidents include overheating, sparking, melting, and fires; 12 injuries, 1 death reported • Risks linked to pendant wiring, overloading, obstructions, and non-Medline accessories • Patients advised to unplug beds unless adjustments are needed, use only Medline accessories • Medline recommends strict adherence to safety guidelines, avoid non-Medline parts • Contact: 866-359-1704 or recalls@medline.com for questions or adverse event reports Original Press Release: www.fda.gov/medical-de... #FDA #USFDA
FDA requests removal of cardiovascular, breast cancer, and dementia risks from HRT boxed warnings to improve informed decision-making • FDA updates hormone therapy labels, removing boxed warnings on cardiovascular, breast cancer, and dementia risks • Several companies have already implemented label changes; more expected • Menopause symptoms include hot flashes, night sweats, vaginal dryness, osteoporosis • Four primary HRT types: systemic combination, estrogen-alone, progestogen-alone, topical vaginal estrogen • FDA emphasizes updated risk info for better patient-provider decisions, not removing endometrial cancer warning Original Press Release: www.fda.gov/consumers/... #FDA #USFDA
FDA approves hormone therapies to ease menopausal symptoms; updates cover drug safety, recalls, and public health tips. Original Press Release: www.fda.gov/consumers/... #FDA #USFDA
FDA emphasizes drug safety, recalls, and new therapies; highlights risks of SARMs, fentanyl patches, and unapproved products. • Hormone therapies aid menopausal symptoms • FDA warns against SARMs, Apetamin, unapproved weight products • Recalls and disposal tips for medicines • Risks of combining medications, dietary supplements • Safety alerts on fentanyl patches, cannabis, and body-building products • Emphasis on biosimilars, treatment options, and public education Original Press Release: www.fda.gov/consumers/... #FDA #USFDA
FDA continues CID Paired Meeting Program to advance innovative trial designs; up to 8 proposals annually for late-stage drug development. • Focus on adaptive, Bayesian, complex designs for unapproved products • Submission deadlines: quarterly, with 45-day review for selection • Up to 2 meetings per quarter, including follow-up within 90 days • Emphasis on trial innovation, unmet therapeutic needs, and substantial evidence support • Public disclosure of design rationale, analysis, and simulation data to promote transparency Original Press Release: www.fda.gov/drugs/deve... #FDA #USFDA
FDA issues warning to Nutrishus Brands over unapproved drug claims and misbranded sugar products • Website claims suggest RxSugar products treat obesity, diabetes, and heart disease • Products classified as unapproved new drugs, violating federal law • Labels lack common name “allulose” and misrepresent nutrient content claims • Syrup’s nutrition label incorrectly lists serving size and calorie content • Enforcement actions highlight regulatory focus on health claims and labeling accuracy Original Press Release: www.fda.gov/inspection... #FDA #USFDA
Wells Fargo & Company (WFC) launches new Series AA and Series B Medium-Term Notes under $15B shelf registration to expand debt issuance capacity. - Series AA issued by Wells Fargo & Company; Series B by Wells Fargo Finance LLC - Notes issued under indentures with Computershare, N.A. as trustee - Distribution agreements in place for direct and agent sales of notes - Prospectus supplements filed February 13, 2026, detailing terms #Form8K #Debt #Financing Full summary: www.perivis.com/note/6... $WFC.US
President Trump announces largest regulatory relief package in history to cut red tape and boost economic growth * Targets over 1,000 federal regulations for rollback * Aims to streamline permitting and reduce compliance costs * Executive order signed to prioritize deregulation efforts * Focus on energy, environment, and financial sectors * Implementation timeline set for next 12 months www.whitehouse.gov/art... #WhiteHouse #Articles
President emphasizes importance of Career and Technical Education Month to workforce development and economic growth * Highlights need for increased investment in CTE programs * Calls for bipartisan support to expand technical training access * Stresses alignment of CTE with emerging industry needs * Urges schools and businesses to collaborate on skill development www.whitehouse.gov/bri... #WhiteHouse #BriefingsStatements
President emphasizes renewed focus on cardiovascular health during American Heart Month * Calls for increased awareness and prevention efforts nationwide * Announces new federal funding for heart disease research * Urges bipartisan support for health initiatives * Highlights progress in reducing heart disease mortality rates www.whitehouse.gov/bri... #WhiteHouse #BriefingsStatements
President Trump announces significant inflation relief with rising real wages and lower prices for Americans • Real wages increase amid inflation decline • Price relief measures benefit consumers nationwide • Policy impacts expected to stabilize household finances • Details on new economic strategies to sustain growth www.whitehouse.gov/art... #WhiteHouse #Articles
RBI Cancels License of Indian Mercantile Co-operative Bank Ltd. Regulatory Action – February 11, 2026: The RBI has canceled the license of Indian Mercantile Co-operative Bank Ltd., Lucknow, effective February 13, 2026, under the Banking Regulation Act, 1949. The bank is prohibited from conducting banking activities, and a winding-up process has been initiated with a liquidator appointed. Depositors are entitled to deposit insurance claims up to ₹5 lakh, with most depositors expected to receive full refunds from DICGC. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
RBI Draft Amendment Directions for REITs and InvITs Draft Amendment Directions – February 6, 2026: The Reserve Bank of India has issued a draft amendment to allow commercial banks to extend financing to Real Estate Investment Trusts (REITs), with prudential safeguards including exposure limits. The guidelines for lending to Infrastructure Investment Trusts (InvITs) are also proposed to be harmonized with those for REITs. Public comments on the draft are invited until March 6, 2026. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
State Government Securities Auction Announcement Auction of State Government Securities – February 17, 2026: The Reserve Bank of India announced an auction of State Government Stocks amounting to ₹37,900 crore, scheduled for February 17, 2026. Bidders can submit competitive and non-competitive bids electronically via the RBI's E-Kuber system, with physical bids accepted only in case of system failure. The auction results will be announced on the same day, with payments due on February 18, 2026, and the new stocks will bear interest at rates determined by RBI, paid semiannually. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Amendment Directions on Capital Market Exposure Issued – October 24, 2025: The Reserve Bank of India issued final Amendment Directions on Capital Market Exposure (CME), incorporating stakeholder feedback. The directions aim to facilitate bank financing for corporate acquisitions, increase lending limits against shares, REITs, and InvITs, and establish a principle-based framework for lending to capital market intermediaries. The amendments update the regulatory framework for commercial banks and small finance banks. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Weekly Statistical Supplement - February 07, 2026 – February 07, 2026: The Reserve Bank of India released its weekly statistical supplement, highlighting a decline in foreign exchange reserves by ₹156,877 crore over the past year to ₹65,006.63 crore as of February 6, 2026. The data also shows an increase in scheduled commercial banks' deposits and credit to the government and the private sector, with total bank credit reaching over ₹26 lakh crore. Liquidity operations during the week involved net absorption of approximately ₹452,543 crore through various instruments. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Treasury Bills Auction Announcement Auction of 91-day, 182-day, and 364-day Treasury Bills announced by the Reserve Bank of India on February 18, 2026. The auction will be price-based using multiple price method, with bids submitted electronically via the E-Kuber system, and results announced on the same day. Payment is due by February 20, 2026, with provisions for physical bids in case of system failure. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Monetary Penalty on DCB Bank Limited – February 06, 2026: The RBI imposed a monetary penalty of ₹29.60 lakh on DCB Bank Limited for non-compliance with directions related to loans against gold ornaments, specifically for failing to maintain the prescribed loan-to-value ratio in certain accounts. The penalty follows a statutory inspection and a process of notice, response, and hearing, based on deficiencies in statutory compliance. The action does not comment on the validity of transactions and is without prejudice to other possible RBI actions. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Monetary Penalty on Bank of Maharashtra Penalty – February 06, 2026: The Reserve Bank of India (RBI) imposed a monetary penalty of ₹32.50 lakh on Bank of Maharashtra for non-compliance with directions related to credit information reporting for Self Help Group members and KYC provisions. The penalty was based on supervisory findings from the Statutory Inspection for Supervisory Evaluation (ISE 2025) and followed a formal show cause process. The action addresses regulatory deficiencies without commenting on the validity of the bank's transactions. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Monetary Penalty on Navi Finserv Limited – February 10, 2026: The RBI imposed a monetary penalty of ₹3.80 lakh on Navi Finserv Limited for non-compliance with directions related to recovery agent conduct, specifically for contacting customers outside permitted hours and not following proper protocols. The penalty was based on supervisory findings and a subsequent review process, without affecting the validity of the company's transactions. The action is taken under RBI's statutory powers and does not preclude further regulatory measures. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Monetary Penalty on IIFL Finance Limited Penalty – February 06, 2026: The RBI imposed a monetary penalty of ₹5.30 lakh on IIFL Finance Limited for non-compliance with asset classification directions, specifically for failing to classify certain accounts as non-performing assets. The penalty follows a statutory inspection and subsequent proceedings, including a show cause notice and hearing. The action is based on regulatory deficiencies and does not comment on the validity of transactions. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Monetary Penalty on CSB Bank Limited – February 06, 2026: The RBI imposed a monetary penalty of ₹63.60 lakh on CSB Bank Limited for non-compliance with directions related to 'Scope of activities to be undertaken of Business Correspondents' and 'Customer Service in Banks'. The penalty followed a statutory inspection and supervisory evaluation, with the bank found to have deficiencies in statutory and regulatory compliance. The action does not comment on the validity of transactions and is without prejudice to further RBI actions. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
Scheduled Banks’ Statement of Position as on January 31, 2026 Banking system data as of January 31, 2026, shows an increase in liabilities and assets compared to previous periods, with total deposits rising to approximately ₹2.54 lakh crore and bank credit reaching over ₹2.05 lakh crore. Borrowings from the Reserve Bank of India also increased to around ₹1.36 lakh crore. The report provides detailed figures on liabilities, assets, investments, and credit, reflecting the financial position of scheduled banks in India. Original Press Release: www.rbi.org.in/scripts... #RBI #CentralBank #India
China's Shaanxi telecom industry gears up for 2026 with new infrastructure and 5G deployment • Focus on high-quality development aligned with 15th Five-Year Plan • Accelerate 'dual gigabit' network and 5G-A commercial rollout • Deepen 'Digital Intelligence Sanqin Signal Upgrade' and 'Energy Gathering 2.0' campaigns • Strengthen industry self-discipline, service quality, and network security • Enhance anti-fraud efforts and network safety for major events and flood season readiness Read More: www.perivis.com/note/2... #ChinaMIIT #China #5G #DigitalEconomy #Telecommunications #IndustrialPolicy